Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over prasugreL: a mUlticenter Randomized Open-label Trial in patientS With ST-elevation Myocardial inFarction Referred for primAry percutaneouS inTERvention.FABOLUS FASTER Trial

Next Previous
X
Search
Trial Profile

Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over prasugreL: a mUlticenter Randomized Open-label Trial in patientS With ST-elevation Myocardial inFarction Referred for primAry percutaneouS inTERvention.FABOLUS FASTER Trial

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jun 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cangrelor (Primary) ; Prasugrel (Primary) ; Tirofiban (Primary) ; Aspirin; Aspirin
  • Indications Cardiovascular disorders; Coronary artery disease; Myocardial infarction; Stroke; Thrombosis; Transient ischaemic attacks
  • Focus Pharmacodynamics
  • Acronyms FABOLUS-FASTER

    • Most Recent Events

    • 04 Aug 2020 Primary endpoint has been met. (Inhibition of platelet activity (IPA, %) with LTA-ADP 20 mol/l)
    • 04 Aug 2020 Results published in the Circulation
    • 29 Jun 2020 According to a Medicure media release, results from this study were recently presented virtually at the PCR e-Course Scientific Sessions, due to the cancellation of EuroPCR 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top